Literature DB >> 20420502

Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua.

Aubree Gordon1, Saira Saborío, Elsa Videa, Roger López, Guillermina Kuan, Angel Balmaseda, Eva Harris.   

Abstract

BACKGROUND. Little is known about the clinical presentation and epidemiology of influenza A H1N1pdm in children in developing countries. We assessed the severity of influenza A H1N1pdm in children in Nicaragua by comparing H1N1pdm cases to seasonal influenza cases in an ongoing cohort study. METHODS. The Nicaraguan Influenza Cohort Study was established in June 2007 to study the burden and seasonality of pediatric influenza in a tropical developing country. During the period from June 2007 through November 2009, a total of 4391 children aged 2-14 years participated in the cohort. We examined the attack rate of clinical influenza and assessed symptoms at first presentation in febrile patients with H1N1pdm versus those with seasonal influenza A or B. RESULTS. The estimated clinical attack rate of H1N1pdm in the cohort was 20.1%, compared to 11.7% and 15.1% for seasonal influenza A and 11.9% and 24.2% for seasonal influenza A and B in 2007 and 2008, respectively. Symptoms significantly associated with H1N1pdm cases versus seasonal influenza A cases were sore throat (adjusted odds ratio [OR], 1.7; 95% confidence interval [CI], 1.2-2.5), wheezing (OR, 5.1; 95% CI, 1.3-19.0), rhonchi (OR, 4.6; 95% CI, 1.4-15.0), crepitations (OR, 16.2; 95% CI, 2.1-128.7), pneumonia (OR, 8.0; 95% CI, 1.7-37.3), nausea (OR, 2.8; 95% CI, 1.5-5.1), and loss of appetite (OR, 2.1; 95% CI, 1.4-3.1). In addition, 3 concurrent influenza and dengue virus coinfections were identified. CONCLUSIONS. Children with influenza A H1N1pdm presented with significantly more symptoms of lower respiratory infection and gastrointestinal symptoms than children with seasonal influenza. The clinical influenza attack rate was high in both pandemic and seasonal years.

Entities:  

Mesh:

Year:  2010        PMID: 20420502     DOI: 10.1086/652647

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  30 in total

1.  Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza.

Authors:  Kevin T Shiley; Gregory Nadolski; Timothy Mickus; Neil O Fishman; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2010-07       Impact factor: 3.254

2.  The Timeline of Influenza Virus Shedding in Children and Adults in a Household Transmission Study of Influenza in Managua, Nicaragua.

Authors:  Sophia Ng; Roger Lopez; Guillermina Kuan; Lionel Gresh; Angel Balmaseda; Eva Harris; Aubree Gordon
Journal:  Pediatr Infect Dis J       Date:  2016-05       Impact factor: 2.129

3.  Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Authors:  R Bodewes; G de Mutsert; F R M van der Klis; M Ventresca; S Wilks; D J Smith; M Koopmans; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

Review 4.  CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.

Authors:  Andrea J Sant; Anthony T DiPiazza; Jennifer L Nayak; Ajitanuj Rattan; Katherine A Richards
Journal:  Immunol Rev       Date:  2018-07       Impact factor: 12.988

5.  Burden of Influenza in Less Than 5-Year-Old Children Admitted to Hospital with Pneumonia in Developing and Emerging Countries: A Descriptive, Multicenter Study.

Authors:  Cédric Dananché; Valentina Sánchez Picot; Thomas Bénet; Mélina Messaoudi; Monidarin Chou; Jianwei Wang; Jean-William Pape; Shally Awasthi; Ashish Bavdekar; Mala Rakoto-Andrianarivelo; Mariam Sylla; Pagbajabyn Nymadawa; Graciela Russomando; Florence Komurian-Pradel; Hubert Endtz; Gláucia Paranhos-Baccalà; Philippe Vanhems
Journal:  Am J Trop Med Hyg       Date:  2018-04-12       Impact factor: 2.345

Review 6.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Global health: the Fogarty International Center, National Institutes of Health: vision and mission, programs, and accomplishments.

Authors:  Joel G Breman; Kenneth Bridbord; Linda E Kupfer; Roger I Glass
Journal:  Infect Dis Clin North Am       Date:  2011-09       Impact factor: 5.982

Review 8.  Review on the impact of pregnancy and obesity on influenza virus infection.

Authors:  Erik A Karlsson; Glendie Marcelin; Richard J Webby; Stacey Schultz-Cherry
Journal:  Influenza Other Respir Viruses       Date:  2012-02-15       Impact factor: 4.380

9.  Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.

Authors:  Sophia Ng; Saira Saborio; Guillermina Kuan; Lionel Gresh; Nery Sanchez; Sergio Ojeda; Eva Harris; Angel Balmaseda; Aubree Gordon
Journal:  Vaccine       Date:  2017-10-03       Impact factor: 3.641

10.  Increased Mortality in Seasonal H3N2 Patients Compared with those with Pandemic 2009 H1N1 in Taiwan, 2009-2010.

Authors:  Shi-Yu Huang; Wen-Chi Huang; Yi-Chun Chen; Ching-Yen Tsai; Ing-Kit Lee
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.